Pacific Biosciences Of California (PACB) Other Working Capital Changes (2010 - 2026)

Pacific Biosciences Of California's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 6.98% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $816000.0, a 104.52% increase from a year earlier, with the FY2025 full-year figure at $723000.0, up 106.07% from the prior year.
• Other Working Capital Changes advanced to $1.4 million in Q1 2026 per PACB's latest filing, from $38000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $6.9 million in Q1 2023 and bottomed at -$3.4 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $25000.0 (2024), against an average of $756117.6.
• Across the five-year window, Other Working Capital Changes plunged 984.5% in 2023 and surged 278.49% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at -$4.1 million in 2022, then rose by 3.01% to -$4.0 million in 2023, then sank by 217.97% to -$12.8 million in 2024, then jumped by 100.3% to $38000.0 in 2025, then jumped by 3650.0% to $1.4 million in 2026.
• Per Business Quant, the three latest PACB Other Working Capital Changes figures stand at $1.4 million (Q1 2026), $38000.0 (Q4 2025), and $2.4 million (Q3 2025).